Table 3.
Variables | Without postoperative complications (n = 284) | With postoperative complications (n = 43) | P value |
---|---|---|---|
Acute kidney injury a | – | 23 (53.5%) | – |
Stage 1 | – | 19 (44.2%) | – |
Stage 2 | – | 4 (9.3%) | – |
Other postoperative complications | – | 30 (69.8%) | – |
Use of vasopressors b | 47 (16.5%) | 19 (44.2%) | < 0.001 |
Duration of vasopressors (hr) c | 18.2 (11.8, 24.7) | 22.1 (8.8, 35.4) | 0.546 |
ICU admission | 174 (61.3%) | 41 (95.3%) | < 0.001 |
Use of MV | 107 (37.7%) | 33 (76.7%) | < 0.001 |
Duration of MV (hr) d | 4.1 (3.4, 4.8) | 14.7 (5.6, 23.5) | 0.003 |
Length of ICU stay (day) e | 1.4 (1.2, 1.5) | 2.2 (1.8, 2.7) | < 0.001 |
Hospital stay after surgery (day) | 5.9 (5.5, 6.2) | 9.5 (7.5, 11.5) | < 0.001 |
In-hospital mortality | 0 (0.0%) | 0 (0.0%) | – |
Data were presented as number of patients (percentage) or mean (95% confidence interval)
ICU Intensive care unit, MV Mechanical ventilation
a Defined as increase in serum creatinine by ≥26.5 μmol/l within 48 h; or increase in serum creatinine to ≥1.5 times baseline, which is known or presumed to have occurred within the prior 7 days; or urine volume < 0.5 ml/kg/h for 6 h. Stage 1 was defined as serum creatinine 1.5–1.9 times baseline or ≥ 26.5 μmol/l increase or urine output < 0.5 ml/kg/h for 6–12 h; stage 2 was defined as serum creatinine 2.0–2.9 times baseline or urine output < 0.5 ml/kg/h for ≥12 h; stage 3 was defined as serum creatinine 3 times baseline or increase to ≥353.6 μmol/l or initiation of renal replacement therapy or urine output < 0.3 ml/kg/h ≥ 24 h or anuria ≥12 h
b Requirement of vasopressors (norepinephrine or epinephrine) to maintain systolic blood pressure ≥ 90 mmHg after surgery
c Results of patients who required vasopressors after surgery
d Results of patients who required mechanical ventilation in the ICU after surgery
e Results of patients who were admitted to the ICU after surgery